Skip Navigation

Faculty Profile

Cletus Arciero, MD

Cletus A. Arciero, MD

Associate Professor of Surgery, Division of Surgical Oncology, Department of Surgery, Emory University School of Medicine

Program Director, Breast Oncology Fellowship, Department of Surgery, Emory

Associate Director for Surgery, Glenn Family Breast Center, Winship Cancer Institute

National Accreditation Program for Breast Centers Representative, Emory Johns Creek Hospital

Colonel (retired), United States Army

Email

cletus.arciero@emory.edu

Certification

American Board of Surgery

Year Joined Emory as a Faculty Member

2015

Bio-Summary

Dr. Arciero recently retired as a Colonel from the United States Army, having served for 25 years. Among the numerous medals he received was the Legion of Merit for a career marked by exemplary service. His positions in the field included chief of surgery of both the 31st and the 256th Combat Support Hospitals in Iraq, and chief of surgery of the 452nd Combat Support Hospital in Kuwait in support of combat operations in Afghanistan.

He has served as chief of surgical oncology, chief of general surgery, and program director of the general surgery residency at Dwight D. Eisenhower Army Medical Center in Fort Gordon, GA. He was also the center's Cancer Liaison Physician of the American Cancer Society Commission on Cancer from 2006-2015.

At Emory, Dr. Arciero's primary clinical locations are Emory University Hospital and Emory Johns Creek Hospital, where he focuses on breast surgery. His academic roles include being the program director of the Emory Breast Oncology Fellowship.

In 2017, Dr. Arciero was appointed Winship Cancer Institute's principal investigator in the Oncology Research Information Exchange Network (ORIEN), the world's largest cancer research collaboration for big data. ORIEN's extensive database allows scientists to analyze and share findings in the development of precision medicine. Along with 14 other top cancer centers around the country, Winship is contributing donated tissue and clinical data for research from consented patients. The research will help investigators better understand cancer at the molecular level, with the goal of developing more targeted cancer treatments.

Affiliations

Education

Honors and Awards

Current Editorships and Editorial Boards

Current Organizational Memberships

Clinical Interests

Research Interests

««return to top